Not Yet Recruiting
Furmonertinib Combined With Anlotinib in Lung Adenocarcinoma Patients With EGFR Mutations and Brain Metastases
NCT06483672
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of Lung Metastatic to Brain, +14 more
- Locations
-
Not specified